NASDAQ:MBOT

Microbot Medical Stock Forecast, Price & News

$7.91

-0.02 (-0.25 %)

(As of 04/14/2021 12:00 AM ET)

Add

Compare

Today's Range

$7.69

Now: $7.91▼

$8.10

50-Day Range

$7.85

MA: $8.39▼

$9.19

52-Week Range

$5.26

Now: $7.91▼

$12.20

Volume83,025 shs

Average Volume163,453 shs

Market Capitalization$56.22 million

P/E RatioN/A

Dividend YieldN/A

Beta3.98

Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable self-propelled locomotive device to treat capabilities within tubular lumens, such as the blood vessels, respiratory, and the urinary and GI tracts; a combination of a guidewire and microcatheter technologies that are used for endoluminal surgery; and maneuver guidewire, microcatheters, and over-the-wire devices within the body's vasculature. It has 37 issued/allowed patents and 15 patent applications pending worldwide. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Biological products, except diagnostic

Sub-IndustryN/A

SectorMedical

Current SymbolNASDAQ:MBOT

Previous Symbol

CUSIPN/A

CIK883975

Webwww.microbotmedical.com

Phone781-875-3605

Employees10

Year FoundedN/A

Debt

Debt-to-Equity RatioN/A

Current Ratio29.32

Quick Ratio29.32

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book Value$5.02 per share

Price / Book1.58

Profitability

EPS (Most Recent Fiscal Year)N/A

Net Income$-7,250,000.00

Net MarginsN/A

Return on Equity-28.95%

Return on Assets-26.60%

Miscellaneous

Outstanding Shares7,108,000

Market Cap$56.22 million

Next Earnings Date5/21/2021 (Estimated)

OptionableNot Optionable

Headlines

Zacks: Analysts Anticipate Microbot Medical Inc. (NASDAQ:MBOT) to Post -$0.33 Earnings Per Share
April 14, 2021 | americanbankingnews.com

Microbot Medical (NASDAQ:MBOT) Shares Cross Above Two Hundred Day Moving Average of $8.00
April 10, 2021 | americanbankingnews.com

Microbot Medical (NASDAQ:MBOT) Posts Earnings Results, Misses Estimates By $0.03 EPS
April 2, 2021 | americanbankingnews.com

Microbot Medical Granted Patent Allowance in Japan; Global Jurisdictions Recognizing Novel 'One & Done' Technology
February 5, 2021 | marketwatch.com

Microbot Medical Granted Patent Allowance in Japan; Global Jurisdictions Recognizing Novel ‘One & Done’ Technology
February 4, 2021 | finance.yahoo.com

Microbot announces successful discussions with FDA on regulation of self-cleaning shunt
January 29, 2021 | seekingalpha.com

Microbot Medical Announces Successful Outcome of its Discussions with FDA Regarding Regulation of Self-Cleaning Shunt
January 27, 2021 | finance.yahoo.com

Microbot Medical Enhances Scientific Advisory Board with World Renowned Interventional Radiologists
January 21, 2021 | finance.yahoo.com

Microbot Medical Announces Positive Results of Additional Animal Feasibility Study with LIBERTYTM Robotic System
January 14, 2021 | finance.yahoo.com

Microbot Medical to Share Current Progress and Expected 2021 Milestones at Upcoming Conferences
January 7, 2021 | finance.yahoo.com

We Think Microbot Medical (NASDAQ:MBOT) Can Afford To Drive Business Growth
December 28, 2020 | finance.yahoo.com

Microbot Medical Secures Patents in Multiple Global Jurisdictions
November 17, 2020 | finance.yahoo.com

Microbot Medical to Highlight Progress and Recent Achievements at H.C. Wainwright 6th Annual Israel Conference
November 9, 2020 | finance.yahoo.com

Microbot Medical Receives Notice of Allowance for U.S. Patent Covering a System for Reducing Dialysis Shunt Stenosis
October 7, 2020 | markets.businessinsider.com

Microbot Medical nabs new U.S. patent for reducing dialysis shunt stenosis
October 7, 2020 | seekingalpha.com

Microbot Medical up 39% on successful study of surgical robot
August 17, 2020 | seekingalpha.com

Stock Alert: Microbot Medical Spikes 25%
August 17, 2020 | nasdaq.com

Microbot Medical Announces Successful Animal Study Utilizing Its LIBERTY™ Robotic System
August 17, 2020 | finance.yahoo.com

Microbot Medical to Share Current Results of a Feasibility Animal Study Utilizing the LIBERTY Robotic System
August 13, 2020 | finance.yahoo.com

Microbot Medical Enters into Agreement to Acquire Novel Technology to Enhance Existing Technology Platforms and Strengthen Pate
August 2, 2020 | www.bloomberg.com

See More Headlines

MarketRank^™

Overall MarketRank^™

1.26 out of 5 stars

Medical Sector

854th out of 2,020 stocks

Biological Products, Except Diagnostic Industry

118th out of 177 stocks

3.5 Analyst's Opinion

Consensus Rating
Microbot Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $20.00, Microbot Medical has a forecasted upside of 152.8% from its current price of $7.91.
Amount of Analyst Coverage
Microbot Medical has received no research coverage in the past 90 days.

2.8 Community Rank

Outperform Votes
Microbot Medical has received 344 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Microbot Medical has received 271 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Microbot Medical has received 55.93% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Microbot Medical and other stocks. Vote “Outperform” if you believe MBOT will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MBOT will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Microbot Medical does not currently pay a dividend.
Dividend Growth
Microbot Medical does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Microbot Medical insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 8.69% of the stock of Microbot Medical is held by insiders.
Percentage Held by Institutions
Only 9.47% of the stock of Microbot Medical is held by institutions.

0.0 Earnings and Valuation

Earnings Growth
Earnings for Microbot Medical are expected to decrease in the coming year, from ($1.25) to ($1.34) per share.
Price to Book Value per Share Ratio
Microbot Medical has a P/B Ratio of 1.58. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

$7.91

-0.02 (-0.25 %)

(As of 04/14/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive MBOT News and Ratings via Email

Sign-up to receive the latest news and ratings for MBOT and its competitors with MarketBeat's FREE daily newsletter.

Microbot Medical (NASDAQ:MBOT) Frequently Asked Questions

Is Microbot Medical a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Microbot Medical in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Microbot Medical stock.
View analyst ratings for Microbot Medical or view top-rated stocks.

What stocks does MarketBeat like better than Microbot Medical?

Wall Street analysts have given Microbot Medical a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Microbot Medical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Microbot Medical?

Microbot Medical saw a decline in short interest in the month of March. As of March 31st, there was short interest totaling 367,300 shares, a decline of 17.7% from the March 15th total of 446,400 shares. Based on an average daily volume of 164,400 shares, the days-to-cover ratio is currently 2.2 days.
View Microbot Medical's Short Interest.

When is Microbot Medical's next earnings date?

Microbot Medical is scheduled to release its next quarterly earnings announcement on Friday, May 21st 2021.
View our earnings forecast for Microbot Medical.

How were Microbot Medical's earnings last quarter?

Microbot Medical Inc. (NASDAQ:MBOT) announced its quarterly earnings results on Tuesday, March, 30th. The biotechnology company reported ($0.37) EPS for the quarter, missing the consensus estimate of ($0.34) by $0.03.
View Microbot Medical's earnings history.

How has Microbot Medical's stock price been impacted by COVID-19?

Microbot Medical's stock was trading at $6.38 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, MBOT stock has increased by 24.0% and is now trading at $7.91.
View which stocks have been most impacted by COVID-19.

When did Microbot Medical's stock split? How did Microbot Medical's stock split work?

Microbot Medical shares reverse split on Monday, May 9th 2016. The 1-12 reverse split was announced on Friday, May 6th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 6th 2016. An investor that had 100 shares of Microbot Medical stock prior to the reverse split would have 8 shares after the split.

What price target have analysts set for MBOT?

1 brokerages have issued twelve-month price targets for Microbot Medical's shares. Their forecasts range from $20.00 to $20.00. On average, they expect Microbot Medical's share price to reach $20.00 in the next twelve months. This suggests a possible upside of 152.8% from the stock's current price.
View analysts' price targets for Microbot Medical or view top-rated stocks among Wall Street analysts.

Who are Microbot Medical's key executives?

Microbot Medical's management team includes the following people:

Mr. Harel Gadot, Co-Founder, Pres, CEO & Chairman (Age 48, Pay $517.8k)
Mr. David Ben Naim CPA, M.B.A., Chief Financial Officer (Age 52, Pay $74.27k)
Prof. Moshe Shoham, Co-Founder, Scientific Director & Member of Scientific Advisory Board (Age 69)
Dr. Simon Sharon, CTO & Chairman of Scientific Advisory Board
Dr. Eric C. Leuthardt, Scientific Director & Member of Scientific Advisory Board
Dr. Eyal Morag M.D., Chief Medical Officer (Age 55)

Who are some of Microbot Medical's key competitors?

Some companies that are related to Microbot Medical include LogicBio Therapeutics (LOGC), ADMA Biologics (ADMA), Gamida Cell (GMDA), Protara Therapeutics (TARA), Voyager Therapeutics (VYGR), Genfit (GNFT), INmune Bio (INMB), Applied Genetic Technologies (AGTC), Fennec Pharmaceuticals (FENC), Axcella Health (AXLA), Checkmate Pharmaceuticals (CMPI), X4 Pharmaceuticals (XFOR), Champions Oncology (CSBR), BiomX (PHGE) and ERYTECH Pharma (ERYP).
View all of MBOT's competitors.

What other stocks do shareholders of Microbot Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Microbot Medical investors own include TransEnterix (TRXC), Advanced Micro Devices (AMD), Athersys (ATHX), NVIDIA (NVDA), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Novavax (NVAX), Pfizer (PFE), Micron Technology (MU) and Sorrento Therapeutics (SRNE).

What is Microbot Medical's stock symbol?

Microbot Medical trades on the NASDAQ under the ticker symbol "MBOT."

How do I buy shares of Microbot Medical?

Shares of MBOT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Microbot Medical's stock price today?

One share of MBOT stock can currently be purchased for approximately $7.91.

How much money does Microbot Medical make?

Microbot Medical has a market capitalization of $56.22 million.

How many employees does Microbot Medical have?

Microbot Medical employs 10 workers across the globe.

What is Microbot Medical's official website?

The official website for Microbot Medical is www.microbotmedical.com.

Where are Microbot Medical's headquarters?

Microbot Medical is headquartered at 25 RECREATION PARK DRIVE UNIT 108, HINGHAM MA, 02043.

How can I contact Microbot Medical?

Microbot Medical's mailing address is 25 RECREATION PARK DRIVE UNIT 108, HINGHAM MA, 02043. The biotechnology company can be reached via phone at 781-875-3605 or via email at [email protected]

This page was last updated on 4/15/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here